Terms: = Testicular cancer AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246 AND Treatment
5 results:
1. Clinicopathologic Characterization of Bilateral testicular Germ Cell Tumors With Immunohistochemical Evaluation of Mismatch Repair and
Al-Obaidy KI; Trevino KE; Idrees MT
Int J Surg Pathol; 2019 Sep; 27(6):619-623. PubMed ID: 30983459
[TBL] [Abstract] [Full Text] [Related]
2. Involvement of the DNA mismatch repair system in cisplatin sensitivity of testicular germ cell tumours.
Rudolph C; Melau C; Nielsen JE; Vile Jensen K; Liu D; Pena-Diaz J; Rajpert-De Meyts E; Rasmussen LJ; Jørgensen A
Cell Oncol (Dordr); 2017 Aug; 40(4):341-355. PubMed ID: 28536927
[TBL] [Abstract] [Full Text] [Related]
3. Resistance mechanisms following cisplatin and oxaliplatin treatment of the human teratocarcinoma cell line 2102EP.
Rennicke A; Voigt W; Mueller T; Fruehauf A; Schmoll HJ; Beyer C; Dempke W
Anticancer Res; 2005; 25(2A):1147-55. PubMed ID: 15868958
[TBL] [Abstract] [Full Text] [Related]
4. Microsatellite instability and loss of heterozygosity have distinct prognostic value for testicular germ cell tumor recurrence.
Velasco A; Riquelme E; Schultz M; Wistuba II; Villarroel L; Koh MS; Leach FS
Cancer Biol Ther; 2004 Nov; 3(11):1152-8; discussion 1159-61. PubMed ID: 15492498
[TBL] [Abstract] [Full Text] [Related]
5. Microsatellite instability of germ cell tumors is associated with resistance to systemic treatment.
Mayer F; Gillis AJ; Dinjens W; Oosterhuis JW; Bokemeyer C; Looijenga LH
Cancer Res; 2002 May; 62(10):2758-60. PubMed ID: 12019150
[TBL] [Abstract] [Full Text] [Related]
